FOR IMMEDIATE RELEASE: May 15, 2025,
Contact: Victor Nieves, vnieves@lifeissues.org 513-719-5813
Pro-life leaders from around the country delivered a powerful letter to Robert F. Kennedy, Jr., Secretary of the U.S. Department of Health and Human Services, and Martin A. Makary, Commissioner of the U.S. Food and Drug Administration, urging them to protect women.
A recent study of commercial insurance data from 865,727 patients highlighted the tremendous real-world danger of the chemical abortion drug. Data show that 94,605 women suffered serious adverse events within forty-five days of taking the drug. This reveals that the drug is twenty-two times more dangerous than previously reported by the FDA.
More than one in ten women experienced symptoms including sepsis, infection, hemorrhaging, and other life-threatening adverse events.
Under the Obama administration, the FDA removed the Risk Evaluation and Mitigation Strategy (REMS) requirement to report these serious adverse events.
In the letter, leaders stated, “We encourage the Administration and FDA to put the safety of women first and take a serious look at the data showing chemical abortion is neither safe nor effective.”
Brad Mattes, President of Life Issues Institute, said, “We know beyond a doubt that chemical abortion is bad for women’s health. It’s time for HHS and the FDA to reevaluate its approval of this toxic drug.”
Life Issues Institute is proud to stand alongside other leaders as we advocate not only for the life of the unborn but for the safety of women across the country. These dangerous chemical abortion drugs must be stopped.
Life Issues Institute is dedicated to changing hearts and minds of millions of people through pro-life education. Organizations and individuals around the world depend upon Life Issues Institute to provide the latest information and effective tools to protect innocent human life from fertilization to natural death.
###
Leave a Reply